CANCER BIOL THER 润色咨询

CANCER BIOLOGY & THERAPY

出版年份:2002 年文章数:155 投稿命中率:60.71%

出版周期:Monthly 自引率:0.8% 审稿周期:平均3.13月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均3.13月 (网友贡献,非官方数据)
投稿命中率
60.71% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量67.31% (2018年为55.33%)
自引率
0.8 %
年文章数
155
期刊官网
点击查看 (点击次数:21843)
点击查看 (点击次数:14113次)
作者需知
点击查看 (点击次数:186次)
期刊简介
稿件收录要求
Impact Factor: 3.294
Five-Year Impact Factor: 3.380
© 2017 Thomson Reuters, Journal Citation Reports ® for 2016 ranks Cancer Biology & Therapy 92 out of 217 in Oncology.

Aims & Scope:
 Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.